Currently, there is evidence supporting the use of either an angiotensin receptor blocker or an angiotensin-converting enzyme inhibitor in the primary-prevention context. However, in the secondary ...

Remme WJ. β blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first? Cardiol. Clin. 25(4), 581–594 (2007). • Critical anaysis of the data from ...